Analysed SONA NANOTECH INC (SNANF:OTCMKTS) News Sources
Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study
20-10-2025
yahoo.com
Why precision oncology may be poised for a reset: a conversation with Sona Nanotech
09-02-2026
proactiveinvestors.com
Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study
16-03-2026
yahoo.com
Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study
07-04-2026
yahoo.com
Sona Nanotech preclinical study shows tumor regression in colorectal cancer model
07-04-2026
proactiveinvestors.com
Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies
13-04-2026
yahoo.com
Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board
16-04-2026
yahoo.com
Sona Nanotech appoints two oncologists to scientific advisory board
16-04-2026
proactiveinvestors.com
Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences
27-04-2026
yahoo.com
What is the current price of SONA NANOTECH INC (SNANF:OTCMKTS)?
The current price of SONA NANOTECH INC (SNANF:OTCMKTS) is $0.218.
SONA NANOTECH INC (SNANF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SONA NANOTECH INC (SNANF:OTCMKTS) since the previous trading day is $0.
SONA NANOTECH INC (SNANF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SONA NANOTECH INC (SNANF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for SONA NANOTECH INC (SNANF:OTCMKTS)?
The most recent average sentiment score for SONA NANOTECH INC (SNANF:OTCMKTS) is 72 out of 100.
What is the most recent average sentiment for SONA NANOTECH INC (SNANF:OTCMKTS)?
The most recent sentiment for SONA NANOTECH INC (SNANF:OTCMKTS) is .
SEC-8K** Filing Available For SONA NANOTECH INC (SNANF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.